slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 24,841-24,870
Pages 1,418
Rows per page 30
Beat
24,841-24,870 of 42,534
18
The table reconciles Net Income to Adjusted EBITDA by adding back taxes, D&A, and adjusting for impairments, acquisition costs, and share-based compensation.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
19
The table provides a detailed breakdown of adjustments including exchange rates, divestitures, and discontinuations to arrive at organic revenue figures.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
20
The table adjusts reported revenue for changes in exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
21
The table reconciles GAAP operating cash flow to a non-GAAP adjusted figure by adding/subtracting specific items like legal settlements, separation costs, and Amoun operating activities.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
The table provides a detailed breakdown of adjustments including impairments, restructuring, and litigation costs.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
23
Standard financial disclosure slide for Bausch Health.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
24
The slide explains the rationale for excluding share-based compensation, acquisition-related costs, loss on extinguishment of debt, separation/IPO costs, and other non-GAAP charges.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
25
Bausch Health Companies | Investor Conference Presentation Deck | 25 slidesBausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
29
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
30
Standard corporate 'at-a-glance' summary slide.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
31
The slide uses a grid of icons and metrics to present company fundamentals and market size.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
Includes disclaimer about non-retouched photos and medical source credits.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a flow diagram to show how business lines were reallocated between two reporting periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
The slide details the financial impact of segment realignments, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a three-column layout to categorize updates by business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
The slide uses a grid-based timeline to map four distinct drug development programs against calendar years from 2019 to 2027.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks financial performance changes for specific product lines following patent expirations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
LOE stands for Loss of Exclusivity. The table tracks financial variance between two forecast periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
The table compares inventory levels across two years, highlighting the change in months on hand for each business unit.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
The table highlights inventory levels for specific business units, showing an increase in months on hand across all units in the 2021 period compared to 2020.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The slide highlights a 6% organic revenue growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
Includes detailed footnotes regarding non-GAAP adjustments and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics and segment-specific growth rates.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit